Serge Briançon

Author PubWeight™ 54.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002 4.48
2 The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 2004 4.47
3 Antioxidant supplementation increases the risk of skin cancers in women but not in men. J Nutr 2007 2.66
4 Effect of supplementation with antioxidants upon long-term risk of hypertension in the SU.VI.MAX study: association with plasma antioxidant levels. J Hypertens 2005 1.67
5 Leisure time physical activity and health-related quality of life. Prev Med 2005 1.24
6 Impact of nephrology referral on early and midterm outcomes in ESRD: EPidémiologie de l'Insuffisance REnale chronique terminale en Lorraine (EPIREL): results of a 2-year, prospective, community-based study. Am J Kidney Dis 2003 1.23
7 Self-rating of quality of life provides additional prognostic information in heart failure. Insights into the EPICAL study. Eur J Heart Fail 2002 1.14
8 Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7). Eur J Cardiothorac Surg 2011 1.09
9 Medical and non-medical determinants of access to renal transplant waiting list in a French community-based network of care. Nephrol Dial Transplant 2006 1.02
10 Pre- and postnatal depression and coping: a comparative approach. J Affect Disord 2005 0.99
11 Quality of life, postnatal depression and baby gender. J Clin Nurs 2007 0.99
12 Association between leisure-time physical activity and health-related quality of life changes over time. Prev Med 2007 0.97
13 Effect of end-stage renal disease on the quality of life of older patients. J Am Geriatr Soc 2003 0.97
14 Health related quality of life of adolescents in Vietnam: cross-cultural adaptation and validation of the Adolescent Duke Health Profile. J Adolesc 2005 0.96
15 Chronic kidney disease: appropriateness of therapeutic management and associated factors in the AVENIR study. J Eval Clin Pract 2009 0.94
16 Serum ferritin, cardiovascular risk factors and ischaemic heart diseases: a prospective analysis in the SU.VI.MAX (SUpplementation en VItamines et Minéraux AntioXydants) cohort. Public Health Nutr 2006 0.93
17 Overweight and obesity prevention for adolescents: a cluster randomized controlled trial in a school setting. Am J Prev Med 2013 0.90
18 Survival of transplanted and dialysed patients in a French region with focus on outcomes in the elderly. Nephrol Dial Transplant 2009 0.89
19 Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels? Br J Nutr 2005 0.87
20 Effect of adapted physical activity sessions in the hospital on health-related quality of life for children with cancer: a cross-over randomized trial. Pediatr Blood Cancer 2010 0.86
21 Management and control of hypertension and proteinuria in patients with advanced chronic kidney disease under nephrologist care or not: data from the AVENIR study (AVantagE de la Nephroprotection dans l'Insuffisance Renale). Nephrol Dial Transplant 2008 0.86
22 Analysis of etiologic factors and periodontal conditions involved with 309 abfractions. J Clin Periodontol 2003 0.86
23 Does compliance with nutrition guidelines lead to healthy aging? A quality-of-life approach. J Acad Nutr Diet 2013 0.86
24 Factors associated with health-related quality of life in renal transplant recipients: results of a national survey in France. Health Qual Life Outcomes 2013 0.86
25 Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: a postintervention follow-up in the SU.VI.MAX Study. Int J Cancer 2010 0.86
26 Iron status and risk of cancers in the SU.VI.MAX cohort. J Nutr 2005 0.86
27 Factors associated with psychological and behavioral functioning in people with type 2 diabetes living in France. Health Qual Life Outcomes 2010 0.86
28 Impact of cancer occurrence on health-related quality of life: a longitudinal pre-post assessment. Health Qual Life Outcomes 2004 0.85
29 Patterns and predictors of kidney function decline in the last year prior to dialysis. Nephron Clin Pract 2009 0.83
30 Clinical and microbiological evaluation of the effectiveness of the Nd:Yap laser for the initial treatment of adult periodontitis. A randomized controlled study. J Clin Periodontol 2005 0.83
31 Final height in children with chronic renal failure who have not received growth hormone. Pediatr Nephrol 2003 0.83
32 Nephrology referral and appropriateness of therapeutic drug care in chronic kidney disease. J Nephrol 2006 0.82
33 Occurrence of coronary artery disease has an adverse impact on health-related quality of life: a longitudinal controlled study. Int J Cardiol 2005 0.82
34 Effect of gender on the association between weight status and health-related quality of life in adolescents. BMC Public Health 2012 0.81
35 Changes in health-related quality of life in patients of self-care vs. in-center dialysis during the first year. Qual Life Res 2007 0.81
36 Analysis, evaluation and adaptation of the ReTransQoL: a specific quality of life questionnaire for renal transplant recipients. Health Qual Life Outcomes 2013 0.81
37 Health-related quality of life in French adolescents and adults: norms for the DUKE Health Profile. BMC Public Health 2011 0.80
38 Contrast-enhanced sonography of the renal transplant using triggered pulse-inversion imaging: preliminary results. Ultrasound Med Biol 2002 0.80
39 Targets for parathyroid hormone in secondary hyperparathyroidism: is a "one-size-fits-all" approach appropriate? A prospective incident cohort study. BMC Nephrol 2014 0.80
40 Impact of predialysis therapeutic practices on patient outcomes during the first year of dialysis: the Pharmacoepidemiologic AVENIR study. Med Care 2012 0.79
41 Impact of first dialysis modality on outcome of patients contraindicated for kidney transplant. Perit Dial Int 2006 0.79
42 [Measuring quality of life in end-stage renal disease. Transcultural adaptation and validation of the specific Kidney Disease Quality of Life questionnaire]. Nephrol Ther 2007 0.79
43 [Chronic kidney disease: do generalists and nephrologists differ in their care?]. Nephrol Ther 2006 0.78
44 Predialysis therapeutic care and health-related quality of life at dialysis onset (The pharmacoepidemiologic AVENIR study). Health Qual Life Outcomes 2011 0.78
45 [SDIALOR: a dialysis patient satisfaction questionnaire]. Nephrol Ther 2008 0.78
46 F2-Isoprostane level is associated with the angiotensin II type 1 receptor -153A/G gene polymorphism. Free Radic Biol Med 2005 0.77
47 Improving ACE inhibitor use in patients hospitalized with systolic heart failure: a cluster randomized controlled trial of clinical practice guideline development and use. J Eval Clin Pract 2003 0.77
48 Intervention dose estimation in health promotion programmes: a framework and a tool. Application to the diet and physical activity promotion PRALIMAP trial. BMC Med Res Methodol 2012 0.77
49 Determinants and patterns of renin-angiotensin system inhibitors' prescription in the first year following kidney transplantation. Clin Transplant 2008 0.77
50 Process evaluation of a school-based overweight and obesity screening strategy in adolescents. Glob Health Promot 2013 0.77
51 Outcomes of patients with delayed dialysis initiation: Results from the AVENIR study. Am J Nephrol 2010 0.77
52 Modelling access to renal transplantation waiting list in a French healthcare network using a Bayesian method. Stud Health Technol Inform 2008 0.77
53 [Angiotensin-converting enzyme inhibitors in congestive heart failure: clinical practice guidelines]. Therapie 2003 0.75
54 [Participation of overweight and socially disadvantaged adolescents in an intervention to promote physical activity in school]. Sante Publique 2017 0.75
55 Adolescents' Physical Activity and Sedentary Behavior: A Pathway in Reducing Overweight and Obesity. The PRALIMAP 2-Year Cluster Randomized Controlled Trial. J Phys Act Health 2014 0.75
56 Effect of adapted physical activity on health-related quality of life among hospitalized children and adolescents (the ACTIV'HOP randomized controlled trial): design and methods. Contemp Clin Trials 2009 0.75
57 [The pharmaco-epidemiology to evaluate clinical practices and their impact on health, regarding an example in nephrology: the AVENIR study]. Nephrol Ther 2012 0.75